GlassScriptPhysician profile
Suzanne Lynn Goodman
NPI 1558411579
$1,181.33
in general payments reported to CMS, 2019-2025
5 companies · $51.17 in 2025
The $51.17 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.22 · 2020: $55.05 · 2021: $57.47 · 2022: $42.55 · 2023: $919 · 2024: $42.87 · 2025: $51.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $840 · Food and Beverage: $141 · Entertainment: $32.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $840.00 |
| Food and Beverage | $140.98 |
| Entertainment | $32.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $872.06 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $174.18 | 2020-2025 | Precision7 |
| Johnson & Johnson Vision Care, INC. | $60.33 | 2023-2024 | Acuvue |
| Coopervision INC. | $58.72 | 2019-2023 | Onefit Contact Lens |
| Tarsus Pharmaceuticals, INC. | $16.04 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.